Login
Change the language. The current language is:
English
Français (Canada)
Menu
Current Issue
All Issues
CADTH Symposium Abstracts
About
About the Journal
The Journal Team
Contact
Subscribe
cadth.ca
Search
Vol 4, No 4 (2024): April
Table of Contents
Viewpoint
Viewpoint: Model Validation Tool
Karen M. Lee
Published
April 16, 2024
PDF
HTML
Reimbursement Recommendations
Teclistamab (Tecvayli)
CADTH
Published
April 24, 2024
PDF
HTML
Drospirenone (Slynd)
CADTH
Published
April 4, 2024
PDF
HTML
Inebilizumab (Uplizna)
CADTH
Published
April 2, 2024
PDF
HTML
Ravulizumab (Ultomiris)
CADTH
Published
April 2, 2024
PDF
HTML
Reimbursement Reviews
Olaparib (Lynparza)
CADTH
Published
April 25, 2024
PDF
HTML
Sacituzumab Govitecan (Trodelvy)
CADTH
Published
April 24, 2024
PDF
HTML
Glofitamab (Columvi)
CADTH
Published
April 23, 2024
PDF
HTML
Evinacumab (Evkeeza)
CADTH
Published
April 17, 2024
PDF
HTML
Efgartigimod Alfa (Vyvgart)
CADTH
Published
April 4, 2024
PDF
HTML
Ibrutinib (Imbruvica)
CADTH
Published
April 2, 2024
PDF
HTML
Calaspargase Pegol (Asparlas)
CADTH
Published
April 2, 2024
PDF
HTML
Health Technology Reviews
Renal Denervation for Uncontrolled Hypertension
CADTH
Published
April 8, 2024
PDF
HTML
View All Issues
